- Home
- MBAV vs SAGE Comparison
MBAV vs SAGE Comparison
Compare MBAV & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBAV
- SAGE
- Stock Information
- Founded
- MBAV 2024
- SAGE 2010
- Country
- MBAV United States
- SAGE United States
- Employees
- MBAV N/A
- SAGE N/A
- Industry
- MBAV
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- MBAV
- SAGE Health Care
- Exchange
- MBAV NYSE
- SAGE Nasdaq
- Market Cap
- MBAV 368.4M
- SAGE 415.0M
- IPO Year
- MBAV 2024
- SAGE 2014
- Fundamental
- Price
- MBAV $10.23
- SAGE $7.43
- Analyst Decision
- MBAV
- SAGE Hold
- Analyst Count
- MBAV 0
- SAGE 19
- Target Price
- MBAV N/A
- SAGE $9.88
- AVG Volume (30 Days)
- MBAV 13.1K
- SAGE 1.3M
- Earning Date
- MBAV 01-01-0001
- SAGE 04-29-2025
- Dividend Yield
- MBAV N/A
- SAGE N/A
- EPS Growth
- MBAV N/A
- SAGE N/A
- EPS
- MBAV 0.24
- SAGE N/A
- Revenue
- MBAV N/A
- SAGE $41,243,000.00
- Revenue This Year
- MBAV N/A
- SAGE $100.39
- Revenue Next Year
- MBAV N/A
- SAGE $70.86
- P/E Ratio
- MBAV $43.06
- SAGE N/A
- Revenue Growth
- MBAV N/A
- SAGE N/A
- 52 Week Low
- MBAV $9.97
- SAGE $4.62
- 52 Week High
- MBAV $10.53
- SAGE $15.74
- Technical
- Relative Strength Index (RSI)
- MBAV N/A
- SAGE 49.65
- Support Level
- MBAV N/A
- SAGE $7.28
- Resistance Level
- MBAV N/A
- SAGE $7.64
- Average True Range (ATR)
- MBAV 0.00
- SAGE 0.37
- MACD
- MBAV 0.00
- SAGE -0.01
- Stochastic Oscillator
- MBAV 0.00
- SAGE 65.57
About MBAV M3-BRIGADE ACQUISITION V CORP
M3-Brigade Acquisition V Corp is a blank check company.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.